Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 6/20 | 0.73 |
| ▸ | HTR2C | P28335 | 1/20 | 0.73 |
| ▸ | PGR | P06401 | 3/20 | 0.73 |
| ▸ | PPARG | P37231 | 2/20 | 0.71 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.71 |
| ▸ | SLC22A8 | Q8TCC7 | 2/20 | 0.71 |
| ▸ | SLC22A11 | Q9NSA0 | 2/20 | 0.71 |
| ▸ | DAO | P14920 | 1/20 | 0.71 |
| ▸ | SNCA | P37840 | 1/20 | 0.71 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.71 |
| ▸ | ABCC4 | O15439 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 5/20 | 0.70 |
| ▸ | ALB | P02768 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.62 |
| ▸ | APEX1 | P27695 | 3/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | RECQL | P46063 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cefuzonam SCHEMBL4811935 | 1.00 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL4811952 | 1.00 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL9573537 | 1.00 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL10363005 | 1.00 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL11144465 | 1.00 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL149484 | 1.00 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL11144468 | 1.00 | NR1I2 (0.73) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL2984096 | 0.99 | NR1I2 (0.72) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL2984090 | 0.99 | NR1I2 (0.72) | NR1I2HTR2CPGRPPARGSLC22A6 | |
| Cefuzonam SCHEMBL27637852 | 0.99 | NR1I2 (0.72) | NR1I2HTR2CPGRPPARGSLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4632 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637481-B2 | Boronic acid derivatives and therapeutic uses thereof | QPEX BIOPHARMA, INC. (US) | 2026-05-26 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| US-20250249110-A1 | ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF | SICHUAN UNIVERSITY (CN) | 2025-08-07 | — | — | US | claimed |
| US-12371429-B2 | Antibiotic resistance-modifying tricyclic heteroaryl compounds and uses thereof | RECREO PHARMACEUTICALS LLC (US) | 2025-07-29 | — | — | US | claimed |
| US-20250222118-A1 | Beta-Lactam-Cannabinoid Conjugate Molecules | DIVERSE BIOTECH INC (US) | 2025-07-10 | — | — | US | claimed |
| US-20250099557-A1 | ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION | SHANGHAI BAO PHARMACEUTICALS CO., LTD. (CN) | 2025-03-27 | — | — | US | claimed |
| US-5637579-A | BETA-LACTAMASE INHIBITORS; BACTERICIDES | HOFFMANN-LA ROCHE INC. (US) | 1997-06-10 | — | — | US | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0680322-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING CLAVULANIC ACID ALONE OR IN COMBINATION WITH OTHER BETA-LACTAM ANTIBIOTICS | SMITHKLINE BEECHAM PLC (GB) | 1995-11-08 | — | — | EP | claimed |
| EP-0384410-B1 | Antimicrobial composition | BANYU PHARMA CO LTD (JP) | 1995-05-17 | — | — | EP | claimed |
| CN-1093089-A | Cephalosporin salts and process for their preparation | HOECHST AG (DE) | 1994-10-05 | — | — | CN | claimed |
| WO-1994016696-A1 | PHARMACEUTICAL FORMULATIONS COMPRISING CLAVULANIC ACID ALONE OR IN COMBINATION WITH OTHER BETA-LACTAM ANTIBIOTICS | SMITHKLINE BEECHAM PLC (GB) | 1994-08-04 | — | — | WO | claimed |
| EP-0603755-A2 | Cephalosporin salts and processes for their preparation | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-06-29 | — | — | EP | claimed |
| EP-0439097-A2 | Cephalosporin derivative | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 1991-07-31 | — | — | EP | claimed |